功能性自焚性水凝与树突交叉连接器,用于控制药物输送.
Silvia Muñoz-Sánchez1, Jue Gong2, Francisco Javier de la Mata1,3,4
1Department of Organic and Inorganic Chemistry and Research Institute in Chemistry ″Andrés M. Del Río″ (IQAR), University of Alcalá, 28805 Madrid, Spain.
概括
我们使用点击化学开发了新的树突性水凝,以控制降解. 这些材料具有可调节的特性和药物释放,显示生物医学应用的前景.
科学领域:
- 生物材料科学是生物材料的科学.
- 聚合物化学 聚合物化学
- 点击"化学"就可以了.
背景情况:
- 控制材料降解对于生物医学应用至关重要.
- 登德里米为材料设计提供独特的特性.
- 点击化学提供了高效和特定的网络形成.
研究的目的:
- 合成和表征一种新的树突性水凝家族.
- 为了研究这些水凝的调节性降解特性.
- 为了评估它们对受控药物释放的潜力.
主要方法:
- 铜辅助的阿齐德-基因循环添加点击反应.
- 合成作为交叉链接器的双功能碳酸树脂体.
- 加入可切割和自燃聚合物.
主要成果:
- 成功合成了具有可调节膨胀和机械性能的状水凝.
- 降解速度从几个小时控制到几天,包括pH控制的条件.
- 黄素释放概况是由网络降解调节的.
结论:
- 树突性水凝可以精确控制降解和性能.
- 自焚性水凝 (SIHs) 显示出生物医学应用的巨大潜力.
- 这些材料使可调节的药物输送系统成为可能.
相关概念视频
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
208
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
208
Transdermal Drug Delivery Systems
233
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
233
Intrauterine Drug Delivery Systems
168
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168


